Overview
Ingenious e-Brain (IeB) stands out by providing comprehensive strategic support to clients throughout the product’s lifecycle—from the preclinical phase to product launch and commercialization. With a track record of 12 years, IeB has been a trusted partner, offering actionable solutions in strategy development, digital innovation and convergence, market transformation, regulatory and competitive intelligence tracking, and commercial analytics. Our strategic planning and analytical insights keep clients informed of the market growth pace & trends and empower them to stay ahead in the competitive landscape.
We offer expertise in healthcare and pharmaceuticals worldwide for all therapeutic areas. Our services encompass several areas, including Competitive Intelligence, Commercial Opportunity Assessment, Disease Landscape and Opportunity Assessment, Evaluation of Patient Journey, Drug Pricing and Market Access, and Brand Strategy.
Our Sector Expertise
Competitive Intelligence
- IeB provides valuable insights by thoroughly analyzing competitors’ internal processes, strategies, strengths, weaknesses, and market positioning.
Market Access
- Navigating the reimbursement landscape and securing favorable coverage decisions on the formularies from the payers
- Identifying key stakeholders, such as payers, healthcare providers, and patient advocacy groups, and tailoring value propositions accordingly
- Engaging with policymakers and advocating for policies that support patient access to innovative therapies
- Navigating the evolving regulatory landscape and adapting market access strategies
Support for M&A and Strategic Opportunities
- Identifying potential partners aligned with clients’ growth objectives
- Initiating preliminary discussions to gauge interest and feasibility
- Facilitating introductions to foster meaningful connections
- Conducting in-depth due diligence to assess partner capabilities and portfolios
Disease Landscape Opportunity Assessment
- Market Sizing and Epidemiology
- Competitive Landscape Analysis
- Patient Journey Mapping
- Treatment Landscape Assessment
- Strategic Scenario Planning
- Value Proposition Development
Product Lifecycle Assessment
- Emerging Market Analysis: Identifying and evaluating growth opportunities in untapped markets.
- Indication Expansion: Strategically broadening product applications to increase market share.
- LOE Strategies: Creating robust plans to counteract the effects of patent expiration and generic competition.
- Profit Optimization: Implementing data-driven approaches to maximize profitability throughout the product lifecycle.
Brand Strategy
- The evolution of communication now goes beyond raising awareness about diseases and drugs to actively educating and shaping perceptions about new products.
Product Value Proposition
- Assessing the viewpoints of Patients, Payers, and Providers plays a fundamental role in defining a distinctive Value Proposition or Target Product Profile (TPP) for a drug during its development phase.
Real World Evidence Studies
- Timely clinical evidence data, which delves into a drug’s utilization, advantages, and potential risks or adverse reactions, is vital for post-market surveillance studies and broadening indications for various diseases or subgroups
Commercial Opportunity Assessment
- Our market assessment approach evaluates the competitive landscape, pricing, market size, and growth opportunities, providing detailed comparisons and KPIs.
- Our deal tracking approach monitors industry partnerships, offering insights and financial modeling to support strategic initiatives.
- Thorough competitive profiling delivers tailored competitor analysis, utilizing a blend of secondary and primary research.
